Atlas Trials

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

Clinical trial NCT00987233 · COMPLETED

Trial details

NCT number
NCT00987233
Sponsor
Apotex Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Seasonal Allergic Rhinitis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.